Sort
15,273 grants matching “antimicrobial resistance”
Novel mechanisms of DNA repair and cell cycle regulation in bacteria
$372,921Lyle Simmons · University Of Michigan At Ann Arbor · R35 · FY2019 · GM
Innate immunity-based screen for bacterial type III secretion system inhibitors
$372,856Victoria Auerbuch Stone · University Of California Santa Cruz · R01 · FY2014 · AI
Health Information Technology to Reduce Healthcare-Associated Infections: HIT-HAI
$372,846Elaine Lucille Larson · Columbia University Health Sciences · R01 · FY2013 · NR
Understanding the role of catheter-associated protein deposition in the development of CAUTI
$372,846Ana Lidia Flores-Mireles · University Of Notre Dame · R01 · FY2022 · DK
Understanding the role of catheter-associated protein deposition in the development of CAUTI
$372,846Ana Lidia Flores-Mireles · University Of Notre Dame · R01 · FY2023 · DK
Understanding the role of catheter-associated protein deposition in the development of CAUTI
$372,846Ana Lidia Flores-Mireles · University Of Notre Dame · R01 · FY2025 · DK
Role of environmental iron in Candida albicans cell wall remodeling and its effect on host-pathogen interaction during oropharyngeal candidiasis
$372,673Sumant Puri · Temple Univ Of The Commonwealth · R01 · FY2022 · DE
Molecular basis of mef-mediated antibiotic resistance in Streptococcus pneumoniae
$372,633David S Stephens · Emory University · R01 · FY2008 · AI
Retrocyclins: circular defensins active against HIV-1
$372,593Alexander M Cole · University Of Central Florida · R01 · FY2006 · AI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia
$372,570John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia
$372,570John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · HL
Development of RC-101 as an Intravaginal Anti-HIV-1 Topical Microbicide
$372,527Alexander M Cole · University Of Pittsburgh At Pittsburgh · U19 · FY2011 · AI
Subproject 2: Identification of Pathways that Can be Targeted for the Development of Novel Therapies for MRSA
$372,500Eleftherios Mylonakis · Massachusetts Eye And Ear Infirmary · P01 · FY2023 · AI
Mechanisms of flagellin-induced protection against microbial keratitis
$372,400Fu-Shin X Yu · Wayne State University · R01 · FY2014 · EY
Mechanisms of flagellin-induced protection against microbial keratitis
$372,400Fu-Shin X Yu · Wayne State University · R01 · FY2015 · EY
GENETIC ANALYSIS OF IMMUNOSENECENCE
$372,345Marc Tatar · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · AG
Multidrug resistant Acinetobacter baumannii,
$372,339Robert A. Bonomo · Case Western Reserve University · R01 · FY2009 · AI
Mechanisms of host protection during infection via the mitochondrial unfolded protein response
$372,319Mark Watson Pellegrino · University Of Texas Arlington · R35 · FY2024 · GM
GLT-1 Enhancers as Drug Candidates for Treating Cocaine Addiction
$372,311Magid Abou-Gharbia · Temple Univ Of The Commonwealth · R01 · FY2017 · DA
Mechanisms of Glycopeptide Resistance in Staphylococci
$372,291Robert S. Daum · University Of Chicago · R01 · FY2006 · AI
Bioinspired antifouling and thromboresistant polymers for blood-contacting interfaces
$372,244Elizabeth Joy Brisbois · University Of Georgia · R01 · FY2020 · HL
Mechanisms of host protection during infection via the mitochondrial unfolded protein response
$372,177Mark Watson Pellegrino · University Of Texas Arlington · R35 · FY2020 · GM
The Contribution of Ribonuclease 7 to Urinary Tract Anitbacterial Defense
$372,177John David Spencer · Research Inst Nationwide Children'S Hosp · R01 · FY2018 · DK
Mechanisms of host protection during infection via the mitochondrial unfolded protein response
$372,177Mark Watson Pellegrino · University Of Texas Arlington · R35 · FY2021 · GM
Addressing Evolving Infectious Threats
$372,099Otto O Yang · University Of California Los Angeles · T32 · FY2023 · AI